A+ A-

Dynamic sales growth for SFS in 2017, parent company of GESIPA®

After 2016 the last year was also a successful year fort he SFS Group in Switzerland, parent company of GESIPA Blindniettechnik GmbH. Operating profit showed a double-digit growth in 2017.

In March SFS published its annual report for 2017. Sales increased in 2017 by 13.7 % to CHF 1,632.7 million. Thanks to the integration of Tegra Medical, SFS improved its position in the medical device industry (from 1.9 % to 6.4%) and also in the American market. Compared to 2016 the sales in America increased by 39.9 % to CHF 281.4 million. Adjusted operating profit (EBITA) rose by 10.7% and amounted to CHF 235.8 million. In the financial year 2018 the SFS Group is focused on strengthening the position with existing customers and on the customer base expansion. You can find the whole annual report here:

SFS annual report